表紙
市場調査レポート

次世代シークエンシング (NGS) の世界市場:2015年〜2019年

Global Next Generation Sequencing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 285559
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
次世代シークエンシング (NGS) の世界市場:2015年〜2019年 Global Next Generation Sequencing Market 2015-2019
出版日: 2015年05月06日 ページ情報: 英文 72 Pages
概要

世界の次世代シークエンシング (NGS) 市場は、2014年〜2019年のCAGRで21.36%の成長が見込まれています。

当レポートでは、世界の次世代シークエンシング (NGS) 市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 ゲノムシークエンシングコスト分析

第8章 設備費

第9章 償還と適用範囲

第10章 NGS検査に対する規制の視点

  • NGS検査の解析性能
  • NGS検査の臨床成績にアクセス

第11章 市場区分:製品別

  • 世界のNGS市場:製品別
  • 世界のNGS市場:試薬・消耗品別
    • 市場規模と予測
  • 世界のNGS市場:設備別
    • 市場規模と予測

第12章 市場区分:エンドユーザー別

  • 世界のNGS市場:エンドユーザー別

第13章 市場区分:技術別

  • 世界のNGS市場:技術別

第14章 地域区分

  • 世界のNGS市場:地域区分別
  • 南北アメリカのNGS市場
    • 市場規模と予測
  • 欧州・中東・アフリカのNGS市場
    • 市場規模と予測
  • アジア太平洋地域のNGS市場
    • 市場規模と予測

第15章 購入基準

第16章 市場成長促進要因

第17章 成長促進要因とその影響

第18章 市場の課題

第19章 成長促進要因と課題の影響

第20章 市場動向

第21章 動向とその影響

第22章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第23章 主要ベンダーの分析

  • Illumina
  • Roche Diagnostics
  • Life Technologies

第24章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR5886

About NGS

Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand. The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run. NGS finds application in whole genome, exome, and transcriptome sequencing that provide a high-resolution and global view of various applications such as the cancer genome. NGS coupled with bioinformatics tools has revolutionized cancer research, diagnosis, and therapy. This technology helps to track and trace the spread of disease and foreign contaminants in drugs.

Technavio's analysts forecast the global next generation sequencing market to grow at a CAGR of 21.36% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global next generation sequencing market for the period 2015-2019. The global next generation sequencing market is divided into two segments: equipment, and reagents and consumables. To calculate the market size, the report considers the revenue generated from the sales of equipment, and reagents and consumables used in next generation sequencing in the following customer segments:

  • Commercial entities such as hospitals and pharmaceutical and life sciences companies
  • Research institutes

Technavio's report, Global Next Generation Sequencing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Illumina
  • Roche Diagnostics
  • Thermo Fischer Scientific

Other Prominent Vendors

  • 10X Genomics
  • 23andMe
  • Ambry Genetics
  • Axeq Technologies
  • Beijing Genomics Institute
  • CLC bio
  • Clontech Laboratories
  • Fluidigm
  • Foundation Medicine
  • GATC Biotech
  • GeneDx
  • GENEWIZ
  • Gnomegen
  • Good Start Genetics
  • Ingenuity Systems
  • Knome
  • NABsys
  • Oxford Nanopore Technologies
  • Pathogenica
  • PerkinElmer
  • RainDance Technologies
  • Rubicon Genomics
  • Sequenom
  • Sigma-Aldrich
  • Source Biosciences
  • Takara Bio

Market Driver

  • Increased Adoption by New Customers
  • For a full, detailed list, view our report

Market Challenge

  • Technical and Implementation Issues
  • For a full, detailed list, view our report

Market Trend

  • Strategic Alliances
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Genome Sequencing Cost Analysis

08. Cost of Equipment

09. Reimbursement and Coverage

10. Regulatory Point of View for NGS Tests

  • 10.1. Analytical Performance of NGS Tests
  • 10.2. Accessing Clinical Performance of NGS Tests
    • 10.2.1. Leveraging Genetic Databases to Evaluate Clinical Performance
    • 10.2.2. Communicate Information about Less Well-known Variants

11. Market Segmentation by Product

  • 11.1. Global NGS Market by Product 2014-2019
  • 11.2. Global NGS Market by Reagents and Consumables
    • 11.2.1. Market Size and Forecast
  • 11.3. Global NGS Market by Equipment
    • 11.3.1. Market Size and Forecast

12. Market Segmentation by End-user

  • 12.1. Global NGS Market by End-user 2014-2019

13. Market Segmentation by Technology

  • 13.1. Global NGS Market by Technology
    • 13.1.1. Sequencing by Synthesis
    • 13.1.2. Ion Semiconductor Sequencing
    • 13.1.3. Sequencing by Ligation
    • 13.1.4. Pyrosequencing
    • 13.1.5. SMRT Sequencing

14. Geographical Segmentation

  • 14.1. Global NGS Market by Geographical Segmentation 2014-2019
  • 14.2. NGS Market in Americas
    • 14.2.1. Market Size and Forecast
  • 14.3. NGS Market in EMEA
    • 14.3.1. Market Size and Forecast
  • 14.4. NGS Market in APAC
    • 14.4.1. Market Size and Forecast

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

  • 22.1. Competitive Scenario
    • 22.1.1. Key News
    • 22.1.2. Mergers and Acquisitions
  • 22.2. Market Share Analysis 2014
  • 22.3. Other Prominent Vendors

23. Key Vendor Analysis

  • 23.1. Illumina
    • 23.1.1. Key Facts
    • 23.1.2. Business Overview
    • 23.1.3. Business Segmentation
    • 23.1.4. Geographical Segmentation by Revenue 2013
    • 23.1.5. Business Strategy
    • 23.1.6. Key Information
    • 23.1.7. SWOT Analysis
  • 23.2. Roche Diagnostics
    • 23.2.1. Key Facts
    • 23.2.2. Business Overview
    • 23.2.3. Business Segmentation by Revenue 2013
    • 23.2.4. Geographical Segmentation by Revenue 2013
    • 23.2.5. Business Strategy
    • 23.2.6. Key Developments
    • 23.2.7. SWOT Analysis
  • 23.3. Life Technologies now part of Thermo Fisher Scientific
    • 23.3.1. Key Facts
    • 23.3.2. Business Overview
    • 23.3.3. Business Segmentation by Revenue 2012
    • 23.3.4. Geographical Segmentation by Revenue 2012
    • 23.3.5. Business Strategy
    • 23.3.6. Recent Developments
    • 23.3.7. SWOT Analysis

24. Other Reports in this Series

List Of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global NGS Market 2014-2019 ($ million)
  • Exhibit 3: Cost per Genome 2001-2014 ($ million)
  • Exhibit 4: Cost per Megabase of DNA Sequence 2001-2014 ($)
  • Exhibit 5: Estimated Cost of NGS Equipment
  • Exhibit 6: Global NGS Market by Product 2014
  • Exhibit 7: Global NGS Market by Product 2019
  • Exhibit 8: Global NGS Market by Product 2014-2019
  • Exhibit 9: Global NGS Market by Reagents and Consumables 2014-2019 ($ million)
  • Exhibit 10: Global NGS Market by Equipment 2014-2019 ($ million)
  • Exhibit 11: Global NGS Market by End-user 2014
  • Exhibit 12: Global NGS Market by Geographical Segmentation 2014
  • Exhibit 13: Global NGS Market by Geographical Segmentation 2019
  • Exhibit 14: Global NGS Market by Geographical Segmentation 2014-2019
  • Exhibit 15: NGS Market in Americas 2014-2019 ($ million)
  • Exhibit 16: NGS Market in EMEA 2014-2019 ($ million)
  • Exhibit 17: NGS Market in APAC 2014-2019 ($ million)
  • Exhibit 18: Market Share Analysis 2014
  • Exhibit 19: Illumina: Business Segmentation
  • Exhibit 20: Illumina: Geographical Segmentation by Revenue 2013
  • Exhibit 21: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 22: Roche Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 23: Life Technologies: Business Segmentation by Revenue 2012
  • Exhibit 24: Life Technologies: Geographical Segmentation by Revenue 2012
Back to Top